How is Rising Cancer Burden Driving Aspiration and Biopsy Needle Demand?
The International Agency for Research on Cancer (IARC) states that “In 2018 there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide”. The organization also forecasts that by 2040, cancer will account for nearly 16.3 million deaths globally. Moreover, the World Health Organization (WHO) estimates that 2.26 million, 2.21 million, and 1.93 million new cases of breast cancer, lung cancer, and colon and rectum cancer were diagnosed in 2020. Additionally, the number of prostate, skin (non-melanoma), and stomach cancer cases is rising at an exponential rate. The increasing cancer burden is encouraging healthcare companies and government organizations to work toward providing better diagnostic facilities, owing to which the aspiration and biopsy needles market will march at a CAGR of 7.2% during 2020–2030. The market was valued at $801.5 million in 2019, and it is expected to generate $1,717.9 million revenue by 2030. Biopsy and aspiration are performed to study t...